Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 28Other hematologic neoplasm 20Lymphoid 20Myeloid 12Classical hematology 3Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 17Melanoma 16Kidney Neoplasms 11Neoplasm Metastasis 10Uterine Cervical Neoplasms 9Prostatic Neoplasms 9Breast Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Anus Neoplasms 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Penile Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Lymphoma 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Vulvar Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Wilms Tumor 2

Interventions

Cyclophosphamide 7fludarabine phosphate 4Flow Cytometry 4Busulfan 4Antilymphocyte Serum 4Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Whole-Body Irradiation 2Thiotepa 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Melphalan 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclosporine 2Carmustine 2Carboplatin 2Alemtuzumab 2thymoglobulin 1sargramostim 1resiquimod 1poly ICLC 1pazopanib 1orantinib 1motexafin gadolinium 1fludarabine 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × fludarabine × Genitourinary × Clear all
NCT00303719 2020-05-12

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
342 enrolled 14 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Kidney Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡